Concord Medical Services Holdings Limited
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Revenue | $50.9M | $65.5M | $95.2M | $97.8M | $162.0M | $106.3M | $71.5M |
| Cost of Revenue | $35.8M | $41.3M | $54.5M | $44.3M | $97.0M | $54.1M | $25.3M |
| Gross Profit | $15.1M | $24.3M | $40.6M | $53.6M | $65.0M | $52.2M | $46.2M |
| Gross Margin | 29.6% | 37.0% | 42.7% | 54.8% | 40.1% | 49.1% | 64.6% |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $36.5M | $29.7M | $20.5M | $8.6M | $17.4M | $11.5M | $12.8M |
| Operating Income | $-32.6M | $-24.3M | $-887.0K | $29.6M | $29.9M | $33.2M | $-25.6M |
| Operating Margin | -64.0% | -37.1% | -0.9% | 30.3% | 18.4% | 31.2% | -35.8% |
| Interest Expense | $13.8M | $12.9M | $8.2M | $8.6M | $7.8M | $2.6M | $1.0M |
| Pretax Income | $-39.0M | $-29.5M | $-811.0K | $28.3M | $27.6M | $31.6M | $-26.2M |
| Income Tax Expense | $4.9M | $8.7M | $11.4M | $13.0M | $12.5M | $10.0M | $7.4M |
| Net Income | $-43.7M | $-37.7M | $-12.1M | $20.1M | $14.2M | $21.0M | $-34.2M |
| Net Margin | -85.9% | -57.5% | -12.7% | 20.5% | 8.8% | 19.8% | -47.8% |
| EPS (Basic) | $-0.34 | $-0.29 | $-0.09 | $0.15 | $0.11 | $0.15 | $-0.24 |
| EPS (Diluted) | $-0.34 | $-0.29 | $-0.09 | $0.15 | $0.11 | $0.15 | $-0.24 |
| Shares Outstanding (Basic) | 130.1M | 130.6M | 134.5M | 134.8M | 135.1M | 138.2M | 141.4M |
| Shares Outstanding (Diluted) | 130.1M | 130.6M | 134.5M | 135.2M | 135.1M | 138.2M | 141.4M |
| Dividends Per Share | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |